Next Article in Journal
The Janus Role of Adhesion in Chondrogenesis
Previous Article in Journal
Progesterone in the Brain: Hormone, Neurosteroid and Neuroprotectant
 
 
Review

The Potential of Metabolomics in the Diagnosis of Thyroid Cancer

1
CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal
2
Chemistry Department, Faculty of Sciences and Technology, University of Coimbra, 3004-535 Coimbra, Portugal
3
Thyroid Study Group, Portuguese Society of Endocrinology, Diabetes and Metabolism, 1600-892 Lisbon, Portugal
4
EPIUnit-Institute of Public Health, University of Porto, 4050-600 Porto, Portugal
5
Department of Chemistry and CICECO, University of Aveiro, 3810-193 Aveiro, Portugal
6
Department of Biomedical Sciences, University of Cagliari, 09042 Cagliari, Italy
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(15), 5272; https://doi.org/10.3390/ijms21155272
Received: 16 June 2020 / Revised: 20 July 2020 / Accepted: 22 July 2020 / Published: 24 July 2020
(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
Thyroid cancer is the most common endocrine system malignancy. However, there is still a lack of reliable and specific markers for the detection and staging of this disease. Fine needle aspiration biopsy is the current gold standard for diagnosis of thyroid cancer, but drawbacks to this technique include indeterminate results or an inability to discriminate different carcinomas, thereby requiring additional surgical procedures to obtain a final diagnosis. It is, therefore, necessary to seek more reliable markers to complement and improve current methods. “Omics” approaches have gained much attention in the last decade in the field of biomarker discovery for diagnostic and prognostic characterisation of various pathophysiological conditions. Metabolomics, in particular, has the potential to identify molecular markers of thyroid cancer and identify novel metabolic profiles of the disease, which can, in turn, help in the classification of pathological conditions and lead to a more personalised therapy, assisting in the diagnosis and in the prediction of cancer behaviour. This review considers the current results in thyroid cancer biomarker research with a focus on metabolomics. View Full-Text
Keywords: metabolomics; thyroid cancer; biomarker; metabolite; diagnosis metabolomics; thyroid cancer; biomarker; metabolite; diagnosis
Show Figures

Graphical abstract

MDPI and ACS Style

Coelho, M.; Raposo, L.; Goodfellow, B.J.; Atzori, L.; Jones, J.; Manadas, B. The Potential of Metabolomics in the Diagnosis of Thyroid Cancer. Int. J. Mol. Sci. 2020, 21, 5272. https://doi.org/10.3390/ijms21155272

AMA Style

Coelho M, Raposo L, Goodfellow BJ, Atzori L, Jones J, Manadas B. The Potential of Metabolomics in the Diagnosis of Thyroid Cancer. International Journal of Molecular Sciences. 2020; 21(15):5272. https://doi.org/10.3390/ijms21155272

Chicago/Turabian Style

Coelho, Margarida, Luis Raposo, Brian J. Goodfellow, Luigi Atzori, John Jones, and Bruno Manadas. 2020. "The Potential of Metabolomics in the Diagnosis of Thyroid Cancer" International Journal of Molecular Sciences 21, no. 15: 5272. https://doi.org/10.3390/ijms21155272

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop